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454.Abstract
Introduction: The overall risk of clinically signiﬁcant post-papillotomy bleeding is 1–4%, most
of them manifest as a delayed hemorrhage 2–5 days after ERCP. Injection method with diluted
epinephrine is the standard ﬁrst line therapy of endoscopic hemostasis in these patients. In
therapy resistant cases endoscopic hemocliping is effective, but optimal positioning of the
hemoclips is difﬁcult and sometimes impossible. Thermal coagulation method with coagulation
forceps combined with prophylactic pancreatic duct stenting could be an alternative in
these cases.
Patients and methods: We present 2 cases of recurrent post-papillotomy bleeding, both were
detected in 1–6 days after the successful ERCP and EST. Standard endoscopic therapy with local
injection of diluted epinephrine and/or application of hemoclips were ineffective. As a second
line endoscopic therapy we used thermal coagulation of the bleeding vessels with coagulationhed by Elsevier GmbH.
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629Endoscopic Therapy of Refractory Post-Papillotomy Bleedingforceps similarly to ESD. At the time of the thermal coagulation a 5F, 3–5 cm prophylactic
pancreatic stent was applied to prevent pancreatitis.
Results: We achieved complete hemostasis in all patients without signs of further rebleeding
or need for surgery. None of our patients developed post-procedure pancreatitis or perforation.
Prophylactic pancreatic stents were safely removed after a few days.
Conclusion: We presented a new, effective and safe second line endoscopic hemostatic method in
patients with therapy resistant post-papillotomy bleeding. Combination of prophylactic pancreatic
stenting and thermal coagulation with coagulation forceps might be suggested as a rescue treatment
in patients with severe post-papillotomy bleeding, resistant to standard endoscopic therapy.
& 2013 The Authors. Published by Elsevier GmbH.Open access under CC BY license.Videos related to this article
Videos related to this article can be found online at http://
dx.doi.org/10.1016/j.vjgien.2013.06.002.1. Background Endoscopic sphincterotomy (ES) is the most frequent
therapeutical maneuver during endoscopic retrograde-
cholangiopancreatography (ERCP). Post-papillotomy bleeding is the second most common
complication of ES [1]. In the Freeman study, the
incidence of clinically signiﬁcant post-papillotomy bleed-
ing was 2%, of which 48% were immediate and 52% were
delayed bleeding [2]. Injection of 1:10,000 diluted epinephrine into the bleed-
ing site of the papilla is the most frequently applied
method to control post-papillotomy bleeding [3]. Kim
et al. reported 100% success with epinephrine injection
in 136 patients with immediate post-ES bleeding, how-
ever rebleeding occurred in eight patients [4]. Repeated
injection therapy might be a treatment of choice, but
complications, such as papillary edema induced post-
procedure pancreatitis could develop after repeated or
large volume of intra-papillary injection of saline and
epinephrine. Recurrent or refractory post-papillotomy bleeding after
initial hemostasis is a demanding clinical situation. No
well accepted clinical strategy exists for management
of recurrent post-papillotomy bleeding. Repeated endo-
scopic procedures are usually attempted prior to per-
forming more invasive therapy, such as surgery. Initially, surgical therapy was used in up to 3% of patients
with refractory post-papillotomy bleeding, but it should
be replaced by second line endoscopic therapy to
diminish higher post-operative mortality after surgery. Endoclip placement can be used for second line endo-
scopic management of refractory post-papillotomy
bleeding, but precise placement of endoclips using
side-viewing endoscopes is technically more difﬁcult
and more often results in misﬁring than with forward-
viewing endoscopes [5]. Endoscopic therapy of refractory post-papillotomy bleeding
with a temporary placement of fully covered self-
expandable metal stents (SEMSs) was a brilliant but expen-
sive proposal by Shah et al., as they demonstrated 100%
success of primary endoscopic hemostasis [6]. The meanduration of stent placement was 8.2 days (range 5–10 days),
and the SEMS was successfully removed in all cases [7]. Selective angiographic embolization can also be an
effective treatment modality of refractory post-
papillotomy bleeding, although the data for its use are
limited [8]. Electrocautery (coagulation) forceps with soft or spray
coagulation mode are actively used for treatment of
bleeding and non-bleeding visible vessels during endo-
scopic mucosal resection (EMR) and endoscopic sub-
mucosal dissection (ESD) [9]. With this innovative tech-
nique, the bleeding point can be coagulated by using a
hemostatic forceps. Several controlled trials from Japan demonstrated that
the application of hemostatic forceps with soft coagula-
tion is a safe and effective method of controlling upper
gastrointestinal peptic ulcer bleeding, too [10]. However, the usefulness of hemostatic forceps coagula-
tion in the endoscopic therapy of refractory post-
papillotomy bleeding has not been investigated so far.
2. Materials Endoscope: Fujinone ED-530XT, EPX-2500.
 ERBE VIO 300D, soft coagulation mode, E6, 80 W.
 Water Jet: Flush Knife Water Jet, Fujinone JW-2.
 Coagulation forceps: Coagrasper™ Hemostatic Forceps
FD-410LR/FD-411UR, Olympus Europe GmbH, Hamburg,
Germany. 5F, 3–5 cm-long prophylactic Geenen stent with internal
ﬂags (Wilson–Cook Co, USA). Guide-wire: 0.025 in., hydrophilic coated standard ERCP
guide-wire (Medwork, Germany). ERCP stent introducer catheter (Oasis, Wilson–Cook Co,
USA).
3. Endoscopic procedures Cleaning of the bleeding site of the Vater papilla using
Dormia basket and high ﬂow water jet ﬂushing with
a Fujinone JW-2 ESD device through a large caliber ERCP
stent introducer catheter. After the precise localization of the papillary oriﬁce
and the bleeding vessel at the site of the previous
Z. Dubravcsik et al.630sphincterotomy, a 0.025-in. hydrophilic coated guide-
wire (Medworks, Germany) is placed into the main
pancreatic duct, and a 5 Fr, 3–5 cm long Geenen prophy-
lactic pancreatic stent with internal ﬂags is next intro-
duced into the pancreatic duct to prevent post-
procedure pancreatitis. Coagulation of the bleeding point by using a hemostatic
forceps (Coagrasper, Olympus, Europe) similarly to ESD
(soft coagulation mode; E6, 80 W). Coagulation process is made step-by-step throughout the
whole margin of the post-sphincterotomy wound, but it is
always started at the bleeding vessel. Prophylactic pancreatic stents can be safely removed
after a few days at a routine gastroscopy procedure using
either polypectomy snare or foreign body forceps.4. Key learning points and tips and tricks Electrocautery (hemostatic) forceps coagulation of the
bleeding vessel is an effective and safe second line
endoscopic therapy in patients with refractory post-
papillotomy bleeding. Optimal visualization of the bleeding point can be achieved
only after a complete removal of the adherent clot from
the sphincterotomy site with the application of a high ﬂow
water jet ﬂushing with a Fujinone JW-2 ESD device. Application of prophylactic pancreatic stents can suc-
cessfully prevent post-procedure pancreatitis, which
may develop due to the occlusion of the pancreatic duct
after excessive papillary coagulation. Therefore, combination of prophylactic pancreatic stent-
ing and thermal coagulation with coagulation forceps
might be suggested as a rescue method in all patients
with severe post-papillotomy bleeding, resistant to stan-
dard endoscopic therapy.5. Complications and risk factors Coagulation at the Vater papilla might cause thermal
injury of the pancreatic tissue and occlusion of the
pancreatic duct oriﬁce leading to post-procedure pan-
creatitis, therefore the application of prophylactic pan-
creatic stents is extremely necessary to prevent such a
complication. Excessive coagulation of the duodenal wall might induce
late duodenal perforation due to transmural burn simi-
larly to post-polypectomy electrocoagulation syndrome,
therefore the site of the forceps coagulation should be
always kept within the edge of the papilla. Repeated unsuccessful attempt of pancreatic duct can-
nulation and/or failure of the prophylactic pancreatic
stent insertion itself might predispose to the develop-
ment of post-ERCP pancreatitis, therefore this procedure
must be attempted only for those endoscopists who
are familiar with routine application of prophlycatic
PD stents.6. Scripted voiceoverVoiceover Text
A 67 year old male patient who received oral anticoagulant
therapy due to implanted mechanical aortic and mitral
valves was admitted to our department with melena six
days after a successful sphincterotomy and stone
extraction for choledocholithiasis. During emergency
duodenoscopy post-papillotomy bleeding was controlled
by local injection of diluted epinephrine. 24 hours later
recurrent and refractory post-papillotomy bleeding
occurred.
At the time of repeated emergency endoscopy a large clot
with fresh blood concealing the papilla is visible in the
descending duodenum. Dormia basket and high ﬂow water
jet ﬂushing is used to remove the adherent clot and clean
the site of bleeding.
We introduce a 5 Fr 4 cm long prophylactic pancreatic stent
ﬁrst to prevent post-procedure pancreatitis.
After repeated washing the bleeding point is coagulated by
using a hemostatic forceps.
Coagulation process is made step-by-step throughout the
whole margin of the post-sphincterotomy wound by using
a hemostatic forceps (Coagrasper) similarly to ESD with a
soft coagulation mode, effect 6, 80 Watts. Complete
hemostasis is achieved by electrocautery forceps
coagulation as a new endoscopic modality.
No re-bleeding observed next day. No complication occured
including post-procedure pancreatitis. The prophylactic
stent was removed few days later.
Normal post-sphincterotomy conditions observed 11 days
later.
A 77 year old woman with previous cholecystectomy had an
enlarged papilla suggesting a papillary adenoma.
Papillotomy caused mild bleeding, but it was controlled
by injection of diluted epinephrine. Cholangiography
showed dilated common bile duct with an obstruction at
the level of papilla.
8 hours after the initial procedure emergency duodenoscopy
was performed due to haematemesis suggesting recurrent
post-papillotomy bleeding. Large amount of fresh clot and
fresh blood was observed in the descending duodenum at
the level of the papilla.
Initially, it is always difﬁcult to make a clear view due to
massive bleeding.
Dormia basket is used ﬁrst for removing the large clot from
the papilla pushing it distally into the duodenum.
Now we are using Fujinon high ﬂow water jet for thorough
washing.
As it seems that the bleeding originates from the whole
circumference of the sphinterotomized papilla and the
ﬁrst line haemostatic therapy of injecting diluted
epinephrine failed, we decided to use the Coagrasper to
coagulate the papilla. Coagulation process should be
made step-by-step throughout the whole margin of the
post-sphincterotomy wound, but always start at the
actively bleeding point. It is also crucial that the site of
the forceps coagulation should always be kept within the
edge of the papilla to avoid perforation. At the time of
the coagulation we pull the tissue a little towards the
631Endoscopic Therapy of Refractory Post-Papillotomy BleedingVoiceover Text
lumen to prevent transmural burn of the duodenal wall
then we gently release the coagulated parts from the
Coagrasper.
At the end of the procedure primary hemostasis is clearly
achieved.
The following day endoscopy showed no signs of bleeding.
The pancreatic stent is in place. The additionally placed
haemoclips are visible.
A week later a gastroscopy was performed to remove the
pancreatic stent. Histology revealed papillary
adenocarcinoma and multiple small liver metastases were
detected on abdominal CT. Finally a biliary SEMS was
applied for long term endoscopic palliation.
Electrocautery forceps coagulation is an effective second
line treatment in refractory post-papillotomy bleeding.
High ﬂow water jet ﬂushing is useful in optimal
visualization of the bleeding point. Prophylactic
pancreatic stents prevent post-procedure pancreatitis in
these cases too. Combination of prophylactic pancreatic
stenting with thermal coagulation with coagulation
forceps might be suggested as a rescue method in severe
post-papillotomy bleeding.
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